Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-05-06-Speech-3-404"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20090506.40.3-404"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, the Presidency, building on the work carried out by the French Presidency, is pursuing actively discussions on the proposal for a directive of the European Parliament and of the Council on the application of patients’ rights in cross-border health care.
The Presidency’s objective is to find solutions that will strike the right balance between the rights of the patients in cross-border health care and the responsibilities of the Member States for the organisation and delivery of health services and medical care.
As the Presidency stated during the plenary debate of 23 April 2009, patients travelling to other Member States should receive full information and high-quality health care. But it is also important to make sure that the directive fulfils the principles of clarity, legal certainty and subsidiarity. Discussions are still ongoing in the Council, so it is impossible to predict whether a political agreement can be reached under the current Czech Presidency. However, the current discussions in the Council suggest that a system of prior authorisation is likely to be limited to specific types of health care. It will be an option for Member States, which they may or may not use. This possibility was recognised by the European Court of Justice under certain conditions.
The Council is also considering accompanying any system of prior authorisation with measures aimed at transparency and full information of the patients about their rights related to receiving cross-border health care.
On the other hand, the directive sets a minimum level of what the Member States have to guarantee to their patients as regards the reimbursement of the costs of cross-border health care. It is the same amount which would be incurred for the same treatment in their home Member State. Nothing prevents Member States from providing their patients who receive cross-border health care with a more advantageous form of reimbursement, even in advance. However, it depends on the Member States’ national policy.
Nevertheless, in cases where the person really needs to receive planned treatment in another Member State and there are objective medical reasons for that, there is already in existence Regulation (EC) 883/2004, under which the patient will receive health care without actually bearing costs himself.
According to the report voted in Parliament’s plenary on 24 April 2009, the European Parliament has also recognised the prior authorisation system as a planning and management tool if it is transparent, predictable, non-discriminatory and subject to clear information for patients.
The Council will study all the amendments with care and will consider how to take account of them in its common position in order to reach an agreement in second reading."@en1
|
| lpv:unclassifiedMetadata | |
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples